WeVote

Bill

Bill

A 1646

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

2024-2025 Regular Session Introduced by Dave Bailey and 1 co-sponsor

New Jersey bill requiring prescription drug pricing transparency and establishing cost-reduction measures to lower medication expenses for residents and state programs.

Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

No documents yet

The official bill text and any amendments will be posted here once available.